Using a multidisciplinary approach consisting in RT QPCR, immunohistochemistry and flow cytometry, the authors demonstrated an up-regulated TLR2 gene expression in HS patients skin lesions, also identifying CD68+ macrophages and CD209+ DCs as the cells expressing TLR2. The gene discussed is TLR2; the disease is histiocytic sarcoma.